Cordis US Executive and Leadership Team

Duke Rohlen, the Chief Executive Officer at Cordis US, directs the overarching strategic vision for the global medical-device enterprise. By prioritizing innovation in interventional cardiovascular technologies, the Chief Executive Officer aligns research and development efforts with the evolving needs of coronary and peripheral vascular disease treatment. Duke Rohlen manages high-level interactions with the Board to ensure long-term growth and operational excellence across all manufacturing divisions. This leadership role involves scaling the production of guidewires, catheters, and stents to maintain market dominance. Through rigorous oversight of corporate initiatives, the Chief Executive Officer drives the company toward sustainable expansion. By fostering a culture of clinical precision, Rohlen secures the competitive position of the organization within the global healthcare landscape, ensuring that every minimally invasive device meets the highest standards of quality and patient safety.

Hernan Domenico, the Chief Financial Officer & Head of Finance (Americas) at Cordis US, manages the fiscal health and capital allocation strategies for the organization. Overseeing financial planning and analysis across the Americas, the Chief Financial Officer & Head of Finance (Americas) ensures robust economic performance for the manufacturing of vascular closure systems and balloons. Hernan Domenico directs budgetary frameworks that support the development of minimally invasive technologies while maintaining strict compliance with international financial regulations. This role involves coordinating with regional leadership to optimize resource distribution and maximize profitability. By analyzing market trends and operational costs, the Chief Financial Officer & Head of Finance (Americas) provides the necessary data to support strategic investment decisions. Ultimately, Domenico strengthens the financial foundation of the company, enabling continued investment in life-saving cardiovascular medical devices.

Bryan Loo, the President, Asia Pacific at Cordis US, drives the commercial strategy and market penetration for interventional cardiovascular technologies throughout the Asia Pacific region. Overseeing the distribution of guidewires, stents, and vascular closure systems, the President, Asia Pacific ensures that healthcare providers across diverse markets receive access to advanced minimally invasive devices. Bryan Loo directs regional sales teams and manages key partnerships with medical institutions to expand the footprint of the company. This leadership role involves navigating complex regulatory environments and adapting product delivery to meet specific regional clinical requirements. By focusing on localized growth strategies, the President, Asia Pacific accelerates the adoption of cardiovascular solutions in emerging markets. Through consistent engagement with regional stakeholders, Loo strengthens the competitive standing of the organization, ensuring that the company remains a preferred partner for cardiovascular care providers across the entire Asia Pacific territory.

Matthew Muscari, the President, Americas at Cordis US, executes the operational and commercial objectives for the company within the North and South American markets. Overseeing the supply chain and distribution networks for catheters, balloons, and other cardiovascular devices, the President, Americas ensures seamless product availability for clinical partners. Matthew Muscari directs regional sales initiatives that emphasize the clinical benefits of minimally invasive technologies in treating coronary and peripheral vascular diseases. This leadership role involves coordinating with cross-functional teams to improve service delivery and customer satisfaction across the region. By analyzing regional market dynamics, the President, Americas identifies opportunities for growth and operational efficiency. Through the strategic management of regional assets, Muscari drives revenue performance and reinforces the reputation of the company as a leader in the medical-device industry, ultimately supporting the broader mission of improving patient health outcomes.

Nancy Pounder, the Chief Human Resources Officer at Cordis US, architects the talent acquisition and organizational development strategies necessary to support a global medical-device manufacturer. Overseeing the recruitment of specialized engineering and clinical talent, the Chief Human Resources Officer ensures the workforce remains aligned with the mission of advancing cardiovascular care. Nancy Pounder directs internal culture initiatives and performance management systems that drive employee engagement across all manufacturing facilities. This leadership role involves collaborating with the C-suite to implement human capital policies that foster innovation in the production of catheters and stents. By optimizing organizational structure, the Chief Human Resources Officer supports the scaling of operations to meet global demand. Through the implementation of comprehensive training programs, Pounder cultivates a high-performing team capable of maintaining the company's 60-year legacy of excellence in medical technology.